Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice.
about
Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with KetamineGroup II mGluRs modulate baseline and arthritis pain-related synaptic transmission in the rat medial prefrontal cortex.Angelica gigas ameliorate depression-like symptoms in rats following chronic corticosterone injection.The Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine Require AMPA Receptor Stimulation in the mPFC and Subsequent Activation of the 5-HT Neurons in the DRN.The Female Encounter Test: A Novel Method for Evaluating Reward-Seeking Behavior or Motivation in MiceDiscovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents.Design of 4-Oxo-1-aryl-1,4-dihydroquinoline-3-carboxamides as Selective Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 2.The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related DisordersPractical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate ReceptorsChronic administration of catechin decreases depression and anxiety-like behaviors in a rat model using chronic corticosterone injections.Alterations in splenic function and gene expression in mice with depressive-like behavior induced by exposure to corticosterone.New hypothesis and treatment targets of depression: an integrated view of key findings.Agmatine, by Improving Neuroplasticity Markers and Inducing Nrf2, Prevents Corticosterone-Induced Depressive-Like Behavior in Mice.Aquaporin-4 knockout exacerbates corticosterone-induced depression by inhibiting astrocyte function and hippocampal neurogenesis.Augmentation therapy with alpha-lipoic acid and desvenlafaxine: a future target for treatment of depression?Subchronic administration of riparin III induces antidepressive-like effects and increases BDNF levels in the mouse hippocampus.Antidepressant activity of fingolimod in mice.Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice.Slc7a11 (xCT) protein expression is not altered in the depressed brain and system xc- deficiency does not affect depression-associated behaviour in the corticosterone mouse model.Anti-anhedonic effect of selective serotonin reuptake inhibitors with affinity for sigma-1 receptors in picrotoxin-treated mice.An organoselenium compound improves behavioral, endocrinal and neurochemical changes induced by corticosterone in mice.Beyond Ketamine: New Approaches to the Development of Safer Antidepressants.Convergent Mechanisms Underlying Rapid Antidepressant Action.
P2860
Q33614178-4B97A3D8-AC0D-4E22-B421-243041D77878Q35738531-B319E1B8-F2C6-4C2D-B143-0F7445175356Q35814474-2C931928-B694-4657-87CA-807C2A1C6687Q36565640-928A660F-4E81-4A20-83D9-25607B0FAC5EQ36588705-F713A8A1-592A-41B2-8A3E-536CAA0337EBQ36733346-D9B091A4-1162-4946-B8EF-070A98CD167AQ36755346-EC3B8356-6A21-4C30-83BC-603A4F1283A3Q37172873-14E5F8E1-7B0E-488A-B558-263EE610EF09Q37183072-5D8E0A05-8686-4FB6-A95E-7C75E33694F5Q37286295-4004D544-0BCB-4F4D-9706-A9A48356935CQ37711960-30ECA866-20E1-47E8-8C96-CE2110DCB151Q38313116-F677556D-C9C6-4B97-A98C-BCF4C7158075Q38875865-17C92571-23A8-4F5D-8AFC-E182DEA52D9CQ39034588-531E47DC-BA79-453B-A423-A6727CE1E356Q39435527-1DA6F3C5-32E6-4F4F-9C67-CC3610DC5270Q41110386-1EC71B05-202E-42DE-B421-9499CFB3C75CQ41359968-6112E985-00D5-4BC1-AD64-8B199ABB45DFQ42066825-5185EFD8-C77D-43AC-BE47-DEB07F1DCF98Q47775588-C6CA5476-5C00-43C9-B06E-FE49AC1414D3Q47915510-51F575AE-DE2E-4434-A6FD-80339A2C2ECBQ47948351-1ECD51E6-9266-4D5E-B86A-50E628033293Q47963007-33CD25CB-60AA-4782-8816-152ED4C6C5E7Q52667723-A03E316D-141E-426F-90B3-7CB034959FBA
P2860
Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Metabotropic glutamate 2/3 rec ...... uced depression model in mice.
@en
Metabotropic glutamate 2/3 rec ...... uced depression model in mice.
@nl
type
label
Metabotropic glutamate 2/3 rec ...... uced depression model in mice.
@en
Metabotropic glutamate 2/3 rec ...... uced depression model in mice.
@nl
prefLabel
Metabotropic glutamate 2/3 rec ...... uced depression model in mice.
@en
Metabotropic glutamate 2/3 rec ...... uced depression model in mice.
@nl
P2093
P1433
P1476
Metabotropic glutamate 2/3 rec ...... duced depression model in mice
@en
P2093
Akemichi Baba
Atsuro Nakazato
Hirotaka Onoe
Kazuhiro Takuma
Naoki Hiramatsu
Ryota Araki
Shigeyuki Chaki
Toshio Matsuda
Toshiyuki Kawasaki
P356
10.1016/J.NEUROPHARM.2012.09.008
P577
2012-09-25T00:00:00Z